1Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol,1999,10:891-900.
2Robinson K, Gupta A, Dennis V, et al.Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.Circulation,1996,94:2743-2748.
3Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.JAMA,1995,274:1049-1057.
5Wald DS, Law M, Morris JK. Homocycsteine and cardio-vascular disease: evidence on causality from a meta-analysis [J].Br med J, 2002, 325(7374) :1202-1206.
6Welch GN, Loscalzo J. Homocysteine and aherothrombosis [J]. N Engl J Med, 1998,338(15): 1042-1050.
7F Oley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease [ J ]. Am J Kidney Dis, 1998,32 (5 Suppl 3) :S112-S119.
8Alessandra F, Perna DI. Possible mechanisms of homocysteinetoxicity[ J]. Kid Int,2003,63 ( Suppl 84) : 137-140.
9Suliman ME, Stenvinkel P, Barany P, et al. Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients [J]. Semin Nephrol, 2006,26( 1 ) :14-19.
10Garibotto G, Sofia A, Valli A, et al. Causes of hyperhomocysteinemia in patients with chronic kidney diseases[J]. Semin Nephrol,2006,26( 1 ) :3-7.
